Gemtaz 1gm Injection
Marketer
Sun Pharmaceutical Industries Ltd
Salt Composition
Gemcitabine (1gm)
Overview Gemtaz 1gm Injection
Oncaspar 1g injection treats various cancers, including non-small cell lung, breast, pancreatic, bladder, and ovarian cancers. Administration is strictly via injection by a healthcare professional, with dosage and frequency determined by your physician based on your condition and potentially adjusted over time. Adhere precisely to your doctor's instructions; incorrect usage or overdosage can lead to severe adverse reactions. Therapeutic effects may take weeks or months to manifest; discontinue use only under medical supervision. Common side effects encompass nausea, vomiting, anorexia, alopecia, and thrombocytopenia. This medication can lower blood cell counts, increasing infection risk. Regular blood tests are essential to monitor blood cell levels, along with cardiac, hepatic, and uric acid levels. Prior to treatment, inform your doctor of any pre-existing heart, liver, or kidney conditions, or concurrent use of antimicrobial agents. Interactions with other medications are possible; disclose all current medications. This medication is contraindicated during pregnancy and lactation. Reliable contraception is crucial for both partners throughout the treatment period.
Primary Ingredients of Gemtaz 1gm Injection
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Gemtaz 1gm Injection
Lung adenocarcinoma, breast carcinoma, pancreatic adenocarcinoma, urothelial carcinoma, and ovarian carcinoma.
Major Benefits of Gemtaz 1gm Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Gemtaz 1gm Injection:
- Nausea
- Vomiting
- Loss of appetite
- Hair loss
- Low blood platelets
- Allergic reaction
- Breathlessness
- Decreased white blood cell count
- Increased liver enzymes
- Anemia (low number of red blood cells)
- Flu-like symptoms
- Blood in urine
- Skin rash
- Protein in urine
How to use Gemtaz 1gm Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Gemtaz 1gm Injection works:
Gemtaz 1gm Injection disrupts cancer cell proliferation by replacing essential DNA and RNA components, thus inhibiting their growth and replication.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Gemtaz 1gm Injection and alcohol may result in significant sedation.
PregnancyCONSULT YOUR DOCTOR
Administering Gemtaz 1gm Injection during pregnancy is contraindicated due to established risks to fetal development. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingUNSAFE
Administering Gemtaz 1gm Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Administration of Gemtaz 1gm Injection can induce drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving should be avoided if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Gemtaz 1gm Injection's use in individuals with renal impairment. Physician consultation is necessary. Pre-treatment and post-treatment assessment of kidney function is recommended.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Gemtaz 1gm Injection to individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Gemtaz 1gm Injection :
NA
Facts to Know About Gemtaz 1gm Injection
| Label | Value |
|---|---|
| Chemical Type | Modified Cytosine |
| Developing Habits | No. |
| Type of Therapy | Cancer Therapeutics |
| Actions | Metabolic inhibitors |
3,018 People bought this recently